CEO Today Healthcare Awards

53 www.ceotodaymagazine.com CEO Today Healthcare Awards 2018 USA CEO of Curium ABOUT RENAUD DEHARENG Renaud founded Curium in 2017 with a vision of developing the largest global platform in nuclear medicine focused on reliable supply of radioactive pharmaceuticals and innovation. Today, Curium is a vertically-integrated institution producing a full portfolio of nuclear medicine products, utilizing 60 production sites and 2,000 employees across the world, to diagnose and treat 35,000 patients a day. Renaud is now leveraging Curium’s unique global infrastructure and industry experience to serve its nuclear medicine clients across the world with an emphasis on compliance, service reliability and new product development. In the first 18 months, Curium achieved significant milestones in its innovation program, most notably: • First supplier that fully converted from highly enriched uranium (weapons-grade) to offer exclusively 100% low enriched uranium generators to the world market, culminating more than 7 years of work • Launched Xenon Xe133 Gas for the evaluation of pulmonary function and lung imaging • Developed 5 other new products focusing on key areas of cancer and neurology diagnosis. All 5 expected to reach market in 2019 and early 2020. • Identified over 200 new products in clinical development that are currently under review for in-licensing or co-investment Renaud has been part of Curium and its predecessors’ companies since 2009. Previously, he served in Arthur Andersen’s strategic consulting division, which he joined after graduating from the UK’s Warwick Business School. Originally from Belgium, Renaud now lives in Washington, D.C. with his wife and three children. In his spare time, he competes in triathlons and enjoys kite surfing. www.curiumpharma.com